New Urine-Based Test Holds Promise for Detecting Aggressive Prostate Cancer

Using next-generation sequencing, the UPSeq test assesses 15 biomarkers to find aggressive prostate cancer that can be missed by biopsies or imaging tests.

9:00 AM

Author | Ian Demsky

prostate cancer cells in blue green and orange in a microscope view with badge on bottom right saying lab note in yellow and navy blue
Castration resistant prostate cancer, human tissue. Mateus Crespo, The Institute of Cancer Research (CC BY 4.0)

Researchers at the University of Michigan Rogel Cancer Center have developed a new urine-based, multi-biomarker test to detect aggressive prostate cancer that performed better than existing biomarker tests in initial preclinical evaluations.

The Urine Prostate Seq test, or UPSeq for short, uses next-generation genomic sequencing to analyze urine collected from men following a digital rectal exam.

The team used machine learning, a form of artificial intelligence, to zero in on 15 RNA transcripts that together create a "liquid biopsy" that outperformed the standard prostate-specific antigen blood test alone, a previous test developed at U-M called Michigan Prostate Score (MiPS) and several other existing biomarker tests, according to findings published in European Urology Oncology.

If a man is found to have an elevated PSA level, doctors first need to determine whether it's a sign of prostate cancer, and if it is cancer, whether that cancer is aggressive.

"The problem is that a patient can have multiple areas of cancer in the prostate and these areas may be different than each other," explains senior study author Simpa Salami, M.D., M.P.H., an assistant professor of urology at Michigan Medicine. "Because of this, both prostate biopsies and MRI scans can miss evidence of aggressive disease. So, this urine test is designed to tell us what's really happening throughout the whole prostate."

The research team believes the test has several potential clinical applications, including early detection of aggressive cancer in men at the time of an initial biopsy, and ruling out aggressive disease in men considering active surveillance — which involves monitoring their cancer through regular physical exams, blood tests, biopsies and imaging tests, and delaying treatment until the cancer shows signs of worsening.

"A novel aspect of this test is that it can detect inheritable mutations in the HOXB13 gene that could warn us that the patient's family members may also be at higher risk for prostate cancer," Salami adds.

The researchers plan to continue to develop and validate the test in additional patients, the authors note.

Disclosure: The test builds on gene fusion research for which U-M and Brigham and Women's Hospital have been issued patents, and of which two of the paper's authors are co-inventors.

Paper cited: "Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer," European Urology Oncology. DOI: 10.1016/j.euo.2021.03.002


More Articles About: Lab Notes Prostate Cancer Cancer Research All Research Topics Cancer Diagnosis Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories veteran sitting with hands closed with person writing notes across from them
Health Lab
Insights into factors contributing to suicide risk among veterans
Recent studies by Michigan Medicine IHPI experts offer new insights into factors contributing to suicide risk among veterans and opportunities to strengthen suicide prevention programs
yellow dices with different emotional faces on each side
Health Lab
Could personality tests help make bipolar disorder treatment more precise? 
Bipolar disorder treatment could become more precisely focused if guided by the results of personality tests that reveal personality styles, or combinations of personality traits.
doctors in surgery room over surgery table with cooler open with labels on it
Health Lab
Why donor hearts fail in cold storage — and how to prevent it
Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows. Fortunately, therapy that is typically prescribed for high blood pressure can target this process to reduce cold preservation associated with cardiac injury. This discovery has potential to improve the consistent function of donor hearts and extend the distance they can be safely transported in cold storage.
mom and child with pacificer and older teen with pacifier in his mouth on other side of blue bench
Health Lab
Are parents waiting too long to stop pacifier use or thumb-sucking in kids?
A national poll looks at how parents tackle thumb-sucking and pacifier use —two habits that can benefit children but that can also be challenging to stop.
joe biden speaking
Health Lab
What does Joe Biden’s prostate cancer diagnosis mean for older patients?
Based on former President Joe Biden's recent diagnosis, a Michigan Medicine urologists discusses routine screening procedures and treatment outcomes.
person looking at ipad with provider on screen smiling
Health Lab
Telemedicine had an impact on carbon emissions equivalent to reducing up to 130,000 car trips each month in 2023
Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of up to 130,000 gas operated vehicles, suggesting it could have a positive effect on climate change, UCLA and Michigan led research finds.